Video

Biocentriq Capacity Update July 2024: Cell & Gene Therapy

Source: BioCentriq

In this presentation form the July 2024 OPCU, learn more about the services offered by BioCentriq, a leading Contract Development and Manufacturing Organization (CDMO) for cell therapy. BioCentriq showcases its state-of-the-art facilities, established track record in GMP drug product release, and customized solutions supported by a seasoned team with strong commitment to quality. BioCentriq spearheads advancements in CAR-T manufacturing and accelerates clinical development timelines through its innovative LEAP platform, playing a notable role in advancing the accessibility and affordability of cell therapy.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

BioCentriq